New balloon treatment aims to keep dialysis access open longer

NCT ID NCT04543539

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing a special balloon coated with a drug to treat blockages in the blood vessels used for dialysis. The balloon is inflated inside the narrowed area to open it up and release medication that may help keep it from closing again. Researchers are following 240 adults with mature dialysis fistulas to check for serious infections and other safety issues over time.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
drug-coated balloon (paclitaxel)
What this could lead to
If successful, this could provide a safer and more effective way to keep dialysis fistulas open, reducing the need for repeat procedures.
What could go wrong
This is a post-approval study focused on long-term safety, not a new treatment. The drug coating may carry risks like infection, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Albany Medical College

    Albany, New York, 12084, United States

  • Cedars-Sinai Heart Institute

    Los Angeles, California, 90048, United States

  • Coastal Vascular and Interventional

    Pensacola, Florida, 32504, United States

  • FirstHealth of the Carolinas

    Pinehurst, North Carolina, 28374, United States

  • Holy Name Medical Center

    Teaneck, New Jersey, 07666, United States

  • Lancaster General Hospital

    Lancaster, Pennsylvania, 17602, United States

  • MUSC Health Dialysis Access Institute

    Orangeburg, South Carolina, 29118, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Medstar Washington Hospital

    Washington D.C., District of Columbia, 20010, United States

  • NCH Healthcare System

    Naples, Florida, 34102, United States

  • Oregon Health & Science University Hospital

    Portland, Oregon, 97239, United States

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina, 29303, United States

  • Stanford University Medical Center

    Stanford, California, 94301, United States

  • Staten Island University Hospital

    Staten Island, New York, 10305, United States

  • The Mount Sinai Hospital

    New York, New York, 10029, United States

  • University of Iowa

    Iowa City, Iowa, 52242, United States

  • University of Michigan Health System - University Hospital

    Ann Arbor, Michigan, 48109, United States

  • University of Virginia Medical Center

    Charlottesville, Virginia, 22903, United States

  • University of Wisconsin-Madison - Meriter Hospital

    Madison, Wisconsin, 53713, United States

  • Yale New Haven Hospital

    New Haven, Connecticut, 06519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.